| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |